1. Trang chủ
  2. » Khoa Học Tự Nhiên

Glycoprotein methods protocols - biotechnology 048-9-297-303.pdf

7 311 0
Tài liệu đã được kiểm tra trùng lặp

Đang tải... (xem toàn văn)

THÔNG TIN TÀI LIỆU

Thông tin cơ bản

Tiêu đề Mucin cDNA Cloning
Tác giả Jean-Pierre Aubert, Nicole Porchet
Người hướng dẫn A. Corfield, Editor
Trường học Humana Press Inc.
Chuyên ngành Biotechnology
Thể loại Chương
Năm xuất bản 2008
Thành phố Totowa
Định dạng
Số trang 7
Dung lượng 94,28 KB

Các công cụ chuyển đổi và chỉnh sửa cho tài liệu này

Nội dung

Glycoprotein methods protocols - biotechnology

Trang 1

24

Mucin cDNA Cloning

Jean-Pierre Aubert and Nicole Porchet

1 Introduction

Much information on the structure, organization, and expression of many genes has

been acquired by using the powerful technique of cDNA cloning (1–5) cDNA clones

differ from genomic DNA clones in that they represent a permanent copy of an mRNA and are representative of the parts of a gene that are expressed as mature RNA This comparison of cDNA clones with their genomic homologs has resulted in the discov-ery of introns in most eukaryotic genes Amino acid sequence of gene products can only be obtained from full-length cDNA sequences cDNA clones can also be used to express the protein products of genes in prokaryotes.

A cDNA library must be created by a series of enzymatic reactions The first one consists in generating a first DNA strand complementary to RNA followed by a re-moval of the RNA strand and replacement by a “second strand” of DNA The new double-stranded DNA is ligated into an appropriate vector Two kinds of vectors can

be used: plasmid or bacteriophage cloning vectors Most of the cDNA cloning experi-ments of human mucins have been done in bacteriophage λgt11 and/or Lambda ZAP®

Vector Both are protein expression cDNA vectors They are designated to generate cDNA libraries from small amounts of DNA (between 5000 and 10,000 clones per nanogram of cDNA) cDNA inserts are cloned into the 3' end ( λgt11) or the 5' end ( λZAP®) of the β-galactosidase gene-coding region, allowing blue/white color screen-ing of clones with inserts in the presence of X-Gal and isopropyl-1-thiol- β-D -galactopyranoside (IPTG).

Due to the large size of the mRNA of mucins (superior to 20 kb) described, it is nearly impossible to obtain a full-length cDNA by screening cDNA libraries There-fore, methods have been developed to amplify DNA sequences from an mRNA tem-plate between a known internal site and the unknown sequences of either the 3' or the

5' end of the mRNA These methods were first described by Frohmann et al (6) and

are referred to as RACE (rapid amplification of cDNA ends).

From: Methods in Molecular Biology, Vol 125: Glycoprotein Methods and Protocols: The Mucins

Edited by: A Corfield © Humana Press Inc., Totowa, NJ

Trang 2

This chapter describes the protocols that have been successfully used in our

labora-tory to clone three cDNAs corresponding to MUC4, MUC5AC, and MUC5B (7).

2 Materials

2.1 Biological Materials

1 Mucus-secreting cultured cells (e.g., LS174T, HT29 MTX) or mucosae from human or animals (e.g., tracheobronchial, gastric, intestinal) are snap-frozen in liquid nitrogen and stored at –80°C until used

2.2 Monoclonal or Polyclonal Antibodies

1 Antibodies must be directed against the peptide moiety of mucins A chemical degly-cosylation of whole mucins or of mucin glycopeptides is needed The quality of the

anti-bodies must be checked by immunohistochemistry before screening (7–10) See Chapters

29 and 30

2.3 Buffers

1 Phenol/chloroform: Add a volume of chloroform equal to that of TE (see item 3) and

saturated phenol and mix Allow the phases to separate Store in dark bottles at 4°C

2 Chloroform: Prepare isoamylalcohol by mixing 24 vol of chloroform with 1 vol of isoamyl alcohol Store at room temperature in a dark bottle

3 TE buffer: Dissolve 1.21 g of Tris base and 0.37 g of EDTA-disodium salt per litre Adjust to pH 8.0 with HCl Sterilize by autoclaving

4 STE buffer: Dissolve 5.84 g of NaCl, 1.21 g of Tris base and 0.37 g of EDTA-disodium salt per liter Adjust pH to 8.0 with HCl Sterilize by autoclaving

5 SM buffer: Dissolve 5.8 g of NaCl, 2 g of MgSO4-7H2O, 6.05 g of Tris base, 5 mL of 20 g gelatine per liter pH to 7.5 with HCl Sterilize by autoclaving

6 TBS buffer: Dissolve 6.05 g of Tris base and 8.76 g of NaCl per liter Adjust pH to 8.0 with HCl Sterilize by autoclaving

7 TBST buffer: Add 0.5 mL of Tween-20 to 1 L of TBS Sterilize by autoclaving

8 3 M sodium acetate: Dissolve 408.1 g of sodium acetate 3 H2O in 800 mL of water Adjust pH to 5.2 with glacial acetic acid Adjust volume to 1 L Dispense in aliquots and sterilize by autoclaving

9 0.25 M EDTA: add 9.3 g of disodium EDTA-2H2O to 80 mL water Adjust to pH 9.0 with

10 N NaOH and adjust the volume to 100 mL Sterilize by autoclaving.

10 10 mM magnesium sulfate (MgSO4-7H2O): Dissolve 7.4 g of magnesium sulfate/100 mL

of distilled water Sterilize by autoclaving

11 0.5 M calcium chloride (CaCl2-2H2O): Dissolve 7.4 g of calcium chloride/100 mL of distilled water Sterilize by autoclaving

12 1 M magnesium chloride (MgCl2-6H2O): Dissolve 20.3 g of magnesium chloride/100 mL

of distilled water Sterilize by autoclaving

13 PEG/NaCl solution: Dissolve 20 g of polyethylene glycol 6000 and 11.7 g of NaCl/100 mL

of SM buffer pH 7.5 Sterilize by autoclaving

14 20% maltose: Dissolve 10 g of maltose/50 mL of distilled water Filter sterilize Store at 2–8°C

15 Ampicillin stock solution: Dissolve 0.25 g of ampicillin/10 mL of distilled water Filter sterilize Store at –20°C

16 Luria-broth (LB): Dissolve in 800 mL of H2O, 10 g of tryptone, 5 g of yeast extract, and

10 g of NaCl Adjust to pH 7.0 with 5 M NaOH and increase volume to 1 L Sterilize by

autoclaving immediately

Trang 3

17 M-broth + ampicillin : just before use, add 20% maltose, to a final concentration of 0.4% and ampicillin, to a final concentration of 50 µg/mL in L-broth

18 L-amp plates: Add 15 g of agar per litre to L-broth, prior to autoclaving Cool to approx

50°C, add 2 mL of ampicillin stock solution, and pour 25 mL into each 90 mm sterile

Petri dish (see Note 1).

19 L-top agar: Add 0.8 g of agar per 100 mL of LB before autoclaving (see Note 2).

20 M-top agar + ampicillin: Melt L-top agar, cool to 45°C and add 20% maltose to a final

con-centration of 0.4 M and ampicillin (25 mg/mL stock) to a final concon-centration of 50 µg/mL

21 Color-selection reagents: 100 mM IPTG; dissolve 23.8 mg isopropyl β-D-thiogalacto-pyranoside/mL in water Filter sterilise 2% X-gal: Dissolve 2% (w/v) 5-bromo-4-chloro-3-indoly-β-D-galactopyranoside in dimethyl formamide Add 10 µL of each solution/mL

of top agar just before plating at 45°C

22 Denaturing solution: Dissolve 87.66 g of NaCl and 20 g of NaOH in 800 mL H2O slowly with care Adjust volume to 1 L

23 Neutralizing solution: Dissolve 175.32 g of NaCl in 500 mL of 1 M Tris-HCl, pH 7.0.

Adjust to 1 L with water

2.4 Kits and Modules

1 Poly A tract® mRNA isolation system (Promega, Charbonnieres, France)

2 mRNA purification kit (Pharmacia Biotech, Orsey, France)

3 cDNA synthesis module (Amersham,Les Ulis, France)

4 cDNA rapid adaptor ligation module (Amersham)

5 cDNA rapid cloning module (Amersham)

6 5'/3' RACE kit (Boehringer Mannheim, Roche Diagnostics, Meylan, France)

2.5 Equipment

1 Several water baths at a range of temperatures from 12 to 90°C and incubators at 32, 37, and 43°C

2 Microcentrifuge

3 Horizontal gel electrophoresis apparatus

4 Thermocycler

3 Methods

3.1 Preparation of mRNA

1 Total RNA is isolated from cultured cells or human mucosae as described in Chapter 25

In spite of the fact that the purification yield of poly A+mucin fraction is very poor, the purification step of polyA+RNA from total RNA cannot be omitted prior to cloning (care-ful elimination of ribosomal RNA is needed)

2 Different technologies are available for the purification of mRNA We have successfully used the poly A tract mRNA isolation system from Promega or the mRNA purification kit from Pharmacia Biotech

3.2 cDNA Synthesis ( see Note 3)

Many kits are commercially available We have used the cDNA synthesis module from Amersham and strictly followed the manufacturer’s instructions.

1 Synthesize the first strand cDNA at 42°C for 1 h by the AMV reverse transcriptase

2 Synthesize the second-strand cDNA by the T4 DNA polymerase after hydrolysis of the

remaining RNA by the Escherichia coli Ribonuclease H.

Trang 4

3 Purify the double-stranded cDNA by phenol/chloroform extraction and ethanol precipitation.

4 If a radiolabeled nucleotide has been added during the synthesis of either the first- or the second-strand cDNA, the yield of cDNA synthesized can be calculated and the quality of the cDNA evaluated by alkaline gel electrophoresis in agarose

3.3 cDNA Cloning ( see Notes 4 and 5)

We have used the cDNA rapid adaptor ligation module and the cDNA rapid cloning module from Amersham and followed the manufacturer’s instructions.

1 Ligation of adaptors to cDNA: Each adaptor contains a blunt- end for ligation with cDNA

and an EcoRI cohesive end to permit ligation with any EcoRI-digested vector.

2 Purification of “adapted” cDNA: Use the spun columns of the kit

3 Phosphorylation of the EcoRI overhangs carrying 5'-hydroxyl groups with T4

polynucle-otide kinase

4 Ligations into λgt11 vector arms: The λgt11 vector arms and the cDNA are ligated to generate recombinant DNA molecules, which also form linear concatemers by ligation of their cos ends

5 In vitro packaging of ligation mixtures: The recombinant DNA molecules are packaged into infectious phage particles The necessary cell extracts are supplied with Amersham λ-DNA in vitro packaging module

6 Phage plating cells: Use Y1090 E coli bacteria.

7 Titration of λgt11 recombinants: As predicted by the manufacturer’s instructions, we have regularly obtained approx 106–107 recombinants per microgram of cDNA

8 Quality of λgt11 cDNA library immunoscreening: The quality of immunoscreening depends on the specificity of the antibodies (monoclonal or polyclonal)

a Plate out the λgt11 library at the required plaque density The best result is obtained when each individual plaque lysis is still well separated from the surrounding plaques

b Induce the expression by overlaying plates with IPTG-impregnated filters Incubate

at 37°C overnight

c Mark the filters and then block the nonspecific binding by incubation of the filters in 20% fetal calf serum (FCS) for 1h at room temperature

d Bind protein-specific primary antibodies diluted in TBS + 20% FCS for at least 12 h

at 4°C

e Wash the filters three times with TBS and then TBST

f Bind peroxidase-labeled second antibody in TBS + 20% FCS for 1 h at room temperature

g Wash the filters as described in step e.

h Incubate filters with DAB substrate + H2O2 diluted in TBS

i Align filter and original plate Identify and pick positive plaque(s) Rescreen to check and isolate clone(s)

9 Characterize the selected clones by purification of phage DNA either by polymerase chain reaction (PCR) using forward and reverse λgt11 primers or by small-scale liquid culture and phage DNA purification

10 The cDNA inserts can now be subcloned into plasmids or M13 phagemids for sequencing

3.4 5'/3' RACE PCR

Since most human mucin mRNAs are usually very large (up to 24 kb), it is not

judicious to try to obtain the full-length cDNA by screening libraries (see Note 6 and

7) We have successfully used the 5'/3' RACE kit from Boehringer Mannheim by

scru-pulously following the manufacturer’s instruction.

Trang 5

3.4.1 5' RACE PCR (Fig 1)

1 Synthesize first-strand cDNA from poly (A+) mRNA using a cDNA-specific primer (des-ignated from the first cDNA sequences obtained) and avian myeloblastosis virus (AMV) reverse transcriptase

2 Used terminal transferase to add a homopolymeric A-tail to the 3'-end of the first strand

3 Then amplify tailed cDNA by PCR using an oligo dT-anchor primer and a second spe-cific primer of the cDNA of interest (nested primer)

4 Clone the PCR product in a vector such as pCR2.1 (Invitrogen) and sequence

3.4.2 3' RACE PCR (Fig 2)

1 Initiate first-strand cDNA synthesis at the natural poly(A+) tail of mRNA using an oligo dT-anchor primer

2 Then directly perform amplification using the PCR anchor primer and a specific primer designated from the first cDNA sequence obtained

4 Notes

1 L-amp plates may be stored inverted in plastic bags at 4°C

2 Sterile L-top agar may be stored solid and melted in a microwave oven before use

3 To optimize the yield of cDNA synthesis, the enzymatic steps must be initiated using as templates freshly purified poly(A+)RNAs

4 Perform at least three separate cDNA-containing ligation reactions to find the optimal cloning efficiency We use generally 20-, 50-, 100-, and 150-ng linkered cDNA for 1 µg

ofλgt11 arms

Fig 1

Trang 6

5 To obtain the best yield of recombinants, a crucial step is the speed with which the extracts are mixed

6 Such cDNA libraries can be screened with oligonucleotide or DNA radiolabeled probes

7 In the case of large human mucin cDNAs, it will probably not be possible to obtain the full-length 5'-end cDNA in one attempt From the new sequence determined, the 5'-end RACE procedure can be repeated

Acknowledgments

The authors wish to thank Dr M Crépin for his collaboration and D Petitprez for her excellent technical assistance.

To the memory of G Vergnes who contributed to selection of the first recombinant clones of human tracheobronchial apomucins.

References

1 Davis, R V., Botstein, D., and Roth, J R (1980) Advanced Bacterial Genetics, Cold

Spring Harbor Laboratory, Cold Spring Harbor, NY

2 Williams, J G (1981) Genetic Engineering, vol 1, (Williamson, R., ed.), Academic Press,

London, pp 1

3 Maniatis, T., Fritsch, E F., and Sambrook, J (1982) Molecular cloning: A Laboratory

Manual, Cold Spring Harbor Laboratory Press , Cold Spring Harbor, NY.

4 Huynh, T V., Young, R A., and Davis, R W (1985) DNA Cloning : A Practical

Approach, vol 1 (Glover, D., ed.), IRL, Oxford, UK, pp 49.

5 Watson, C J and Jackson, J F (1985) DNA Cloning : A Practical Approach vol 1

(Glover, D., ed.), IRL, Oxford, UK, pp 79

Fig 2

Trang 7

6 Frohmann, M (1994) Beyond classic RACE PCR Methods Appl 4, 540–558.

7 Aubert, J P., Porchet, N., Crépin, M., Duterque-Coquillaud, M., Vergnes, G., Maz-zuca, M., Debuire, B., Petitprez, D., and Degand, P (1991) Evidence for different human

tracheobronchial mucin peptides deduced from nucleotide cDNA sequences Am J Respir.

Cell Mol Biol 5, 178–185.

8 Crépin, M., Porchet, N., Aubert, J P., and Degand, P (1990) Diversity of the peptide

moiety of human airway mucins Biorheology 27, 471–484.

9 Gum, J R., Byrd, J C., Hicks, J W., Toribara, N W., Lamport, D T A., and Kim, Y S (1989) Molecular cloning of human intestinal mucin cDNAs Sequence analysis and

evi-dence for genetic polymorphism J Biol Chem 264, 6480–6487.

10 Toribara, N W., Robertson, A M., Ho, S B., Kuo, W L., Gum, E., Hicks, J W., Gum, J R., Byrd, J C., Siddiki, B., and Kim, Y S (1993) Human gastric mucin Identification of

a unique sequence by expression cloning J Biol Chem 268, 5879–5885.

Ngày đăng: 23/09/2012, 19:26

TỪ KHÓA LIÊN QUAN